SCHEMBL487578

SCHEMBL487578

C/C=C(\C)C([O])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246006 1.00
SCHEMBL246005 1.00
Bicarbonate SCHEMBL11119225 0.80 FFAR3 (0.46)
Bicarbonate SCHEMBL27641392 0.74 PTGS1 (0.40)
SCHEMBL276990 0.72 LMNA (0.39)
SCHEMBL11026124 0.72 LMNA (0.39)
SCHEMBL380121 0.72
SCHEMBL756363 0.72 LMNA (0.39)
SCHEMBL2029340 0.72
SCHEMBL380120 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10611964-B2 Polymerizable compound, polymerizable composition and liquid crystal display device JNC CORPORATION (JP) 2020-04-07 US claimed
EP-2990424-B1 POLYMERIZABLE COMPOUND AND POLYMERIZABLE COMPOSITION JNC CORP (JP) 2019-01-30 EP claimed
US-9714210-B2 Liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2017-07-25 US claimed
US-20170157301-A1 LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS TECHNISCHE UNIVERSITÄET WIEN (AT) 2017-06-08 US claimed
EP-3160462-A1 LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS Technische Universität Wien (AT) 2017-05-03 EP claimed
US-20160083330-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2016-03-24 US claimed
US-20160075950-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2016-03-17 US claimed
EP-2990424-A1 POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2016-03-02 EP claimed
WO-2015196228-A1 LEOLIGIN DERIVATIVES AS SMOOTH MUSCLE CELL PROLIFERATION INHIBITORS TECHNISCHE UNIVERSITÄT WIEN (AT) 2015-12-30 WO claimed
EP-0254583-B1 Parasiticidal milbemycin derivatives, a process for their production, and compositions containing the same BEECHAM GROUP PLC (GB) 1994-09-07 EP claimed
US-4434179-A POLYPRENYL DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1984-02-28 US claimed
US-20230398096-A1 COMPOSITION COMPRISING TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-12-14 US disclosed
EP-3160462-B1 LEOLIGIN DERIVATIVES AS PROLIFERATION INHIBITORS OF SMOOTH MUSCLE CELLS UNIV WIEN TECH (AT) 2023-11-22 EP disclosed
EP-4265602-A2 LEOLIGIN DERIVATIVES AS PROLIFERATION INHIBITORS OF SMOOTH MUSCLE CELLS TECHNISCHE UNIVERSITÄT WIEN (AT) 2023-10-25 EP disclosed
US-20230142119-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-11 US disclosed
EP-0214708-A2 Griseolic acid derivatives, their preparation and their use SANKYO COMPANY LIMITED (JP) 1987-03-18 EP disclosed
US-4434179-A POLYPRENYL DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1984-02-28 US disclosed
US-4260551-A ALIPHATIC OR AROMATIC ESTERS, ANTIULCER AGENTS SANKYO COMPANY LIMITED (JP) 1981-04-07 US disclosed
US-4192953-A TREATMENT OF PEPTIC ULCERS SANKYO COMPANY LIMITED (JP) 1980-03-11 US disclosed
US-4059641-A ANTIULCER SANKYO COMPANY LIMITED (JA) 1977-11-22 US disclosed